https://www.selleckchem.com/pr....oducts/elexacaftor.h
92 (95% CI 3.43-4.48)] was associated with increased odds of AMA discharge. Among IDU-IE, women [AOR 1.21 (95% CI 1.04-1.41)] and Hispanics [AOR 1.32 (95% CI 1.03-1.69)] had increased odds of AMA discharge, which differed from non-IDU-IE. Over nearly 6-years, odds of AMA discharge increased 12% per year for IDU-IE [AOR 1.12 (95% CI 1.07-1.18)] and 6% per year for non-IDU-IE [AOR 1.06 (95% CI 1.00-1.13)]. AMA discharges have risen among individuals with IDU-IE and non-IDE-IE. Among those who inject drugs, AMA discharges were more com
Gefällt mir
Kommentar
Teilen
